The Metabolite Profiling Facility (MPF) provides state-of-the-art technologies that enable both qualitative (defining all components of a metabolome) and quantitative (determining differential ...
The company’s lead asset, endoxifen, is progressing well in mid-stage clinical trials for breast cancer and high breast density indications. Despite being a metabolite of the well-established drug ...